GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Increased
Reduced
Net increased
Funds Holding
5,691
Funds Holding Change
-105
Funds Holding Growth
-2%
Value
$1.48T
Holding in Top 10
747
Top 10 Change
-78
Top 10 Growth
-9%
Value Growth
-2%
New
232
Increased
2,611
Reduced
2,470
Closed
242
Capital Inflow
$302B
Capital Outflow
$59.7B
Net Capital Flow
+$243B
Capital Flow Change
+$204B
Calls
$21.5B
Puts
$25.3B
Net Calls
-$3.83B
Put/Call Ratio
1.18